Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
ELVN | Enliven Therapeutics, Inc. | Cfo & Coo | $418K | Feb 22, 2023 | ||
UPB | Upstream Bio, Inc. | CFO and COO | Oct 10, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|